Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
Xue Han,Yakun Yang,Muqing Zhang,Li Li,Yucong Xue,Qingzhong Jia,Xiangting Wang,Shengjiang Guan
DOI: https://doi.org/10.2147/DDDT.S386805
2022-12-02
Abstract:Xue Han, 1, &ast Yakun Yang, 1, &ast Muqing Zhang, 2, 3 Li Li, 4 Yucong Xue, 2 Qingzhong Jia, 4 Xiangting Wang, 2, 5 Shengjiang Guan 3, 6 1 School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, People's Republic of China; 2 College of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, People's Republic of China; 3 Affiliated Hospital, Hebei University of Chinese Medicine, Shijiazhuang, People's Republic of China; 4 School of Pharmacy, Hebei Medical University, Shijiazhuang, People's Republic of China; 5 Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, Shijiazhuang, People's Republic of China; 6 School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiangting Wang, College of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China, Email Shengjiang Guan, Affiliated Hospital, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China, Email Purpose: Despite significant advances in interventional treatment, myocardial infarction (MI) and subsequent cardiac fibrosis remain major causes of high mortality worldwide. Liquiritin (LQ) is a flavonoid extract from licorice that possesses a variety of pharmacological properties. However, to our knowledge, the effects of LQ on myocardial fibrosis after MI have not been reported in detail. The aim of our research was to explore the potential role and mechanism of LQ in MI-induced myocardial damage. Methods: The MI models were established by ligating the left anterior descending branch of the coronary artery. Next, rats were orally administered LQ once a day for 14 days. Biochemical assays, histopathological observations, ELISA, and Western blotting analyses were then conducted. Results: LQ improved the heart appearance and ECG, decreased cardiac weight index and reduced levels of cardiac-specific markers such as CK, CK-MB, LDH, cTnI and BNP. Meanwhile, LQ reduced myocardial infarct size and improved hemodynamic parameters such as LVEDP, LVSP and ±dp/dt max . Moreover, H&E staining showed that LQ attenuated the pathological damage caused by MI. Masson staining showed that LQ alleviated myocardial cell disorder and fibrosis while reducing collagen deposition. LQ also decreased the levels of oxidative stress and inflammation. Western blotting demonstrated that LQ significantly down-regulated the expressions of Collagen I, Collagen III, TGF-β 1, MMP-9, α-SMA, CCL5, and p-NF-κB. Conclusion: LQ protected against myocardial fibrosis following MI by improving cardiac function, and attenuating oxidative damage and inflammatory response, which may be associated with inhibition of CCL5 expression and the NF-κB pathway. Keywords: liquiritin, cardiac fibrosis, myocardial infarction, CCL5 expression, NF-κB signaling pathway Timely and complete myocardial reperfusion (eg, thrombolytic therapy or primary percutaneous coronary intervention) is an effective treatment to reduce ischemic injury and infarct size, but myocardial fibrosis (MF) after myocardial infarction (MI) still leads to adverse cardiac remodeling and high mortality. 1,2 Fibrosis represents one of the primary mechanisms involved in the repair process after MI, which may manifest as interstitial and replacement fibrosis. 3,4 MF is an irreversible structural change of the heart caused by excessive deposition of extracellular matrix (ECM). 5 Collagen I (50–85%) and collagen III (10–45%) are the major collagens in the myocardial ECM. 6 Myofibroblasts express α-smooth muscle actin (α-SMA) and coordinate deposition of collagen and secretion of multiple ECM proteins. 7 Matrix metalloproteinases (MMPs) are known regulators of cardiac remodeling. 8 All kinds of cytokines, inflammatory factors, and the oxidative stress may promote fibroblast proliferation and synthesis of large amounts of collagen, leading to MF. 9–11 It is well known that the inflammatory response could further aggravate the cardiac remodeling and myocardial damage. 12 C-C chemokine motif ligand 5 (CCL5) is a typical pro-inflammatory chemokine. CCL5 is also named regulated on activation normal T cell expressed and secreted (RANTES). 13 During various pathological processes, CCL5 enhances and directs leukocyte migration to inflammatory response lesions. 14,15 CCL5 is expressed in a variety of cells and could -Abstract Truncated-